| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/17/2007 | CN1294971C 'Niaoduqing' granular infusion for treating uraemia |
| 01/17/2007 | CN1294970C Traditional Chinese medicine capsule for treating insomnia and method for preparing same |
| 01/17/2007 | CN1294968C Chinese herbal medicine capsule for treating epilepsia |
| 01/17/2007 | CN1294967C Externally applied plaster for treating hypertension |
| 01/17/2007 | CN1294961C Oral liquid for curing myocardial ischemia and process for preparing the same |
| 01/17/2007 | CN1294958C Chinese medicinal preparation for treating acne and production thereof |
| 01/17/2007 | CN1294957C Ointment for treating spur |
| 01/17/2007 | CN1294951C Prepared Chinese medicine for dredging oviduct |
| 01/17/2007 | CN1294947C Pill for treating alopecia |
| 01/17/2007 | CN1294946C Chinese medicine suppository for curing gynecopathy, and its preparing method and use method |
| 01/17/2007 | CN1294943C Cape jasmine buccal tablet and its prepn process |
| 01/17/2007 | CN1294942C Pain stopping capsule |
| 01/17/2007 | CN1294941C Chinese compound medicinal preparation for treating asthma and method for preparing the same |
| 01/17/2007 | CN1294938C Skin inflammation eliminating tincture |
| 01/17/2007 | CN1294936C Medicine for treating diabetes and its preparation method |
| 01/17/2007 | CN1294931C Compound collunarium oil and preparation method thereof |
| 01/17/2007 | CN1294930C Medication for treating cough caused by inflammation of upper respiratory tract |
| 01/17/2007 | CN1294926C Chinese medicine composition prescription for treating pulmonary heart disease and its preparation process |
| 01/17/2007 | CN1294925C Chinese medicine for treating hypertension and hyperlipemia and preparation thereof |
| 01/17/2007 | CN1294919C Externally used medicine bag for treating piles and preparation method thereof |
| 01/17/2007 | CN1294918C Effervesce tablet of ginseng |
| 01/17/2007 | CN1294917C Injection for curing italitai disease |
| 01/17/2007 | CN1294916C Pernio ointment for treating itch and pain |
| 01/17/2007 | CN1294914C Chinese medicinal injection liquid for giving up drug |
| 01/17/2007 | CN1294913C Medication combination of containing finasteride and cyclodextrin or ramification |
| 01/17/2007 | CN1294907C 盐酸氨溴索颗粒剂 Ambroxol Hydrochloride Granules |
| 01/17/2007 | CN1294904C Method for preventing content adhesion in soft capsule with high solid content |
| 01/17/2007 | CN1294903C Loquat drip pill for treating cough |
| 01/17/2007 | CN1294902C Cough and asthma relieving drop pills prepared using dahurian rhododendron leaf |
| 01/17/2007 | CN1294901C Embolism eliminatinging drop pills with qi invigorating, blood flow promoting and collateral dredging function |
| 01/17/2007 | CN1294900C Tendril-leaved fritillary bulb cough-relieving drop pills |
| 01/17/2007 | CN1294899C Black soya bean oil contained compound gelling agent |
| 01/17/2007 | CN1294847C Health food for diabetic |
| 01/16/2007 | US7164054 Liner for patch |
| 01/16/2007 | US7164005 Microencapsulation and sustained release of biologically active polypeptides |
| 01/16/2007 | US7163930 Pharmaceutical compositions and methods relating to fucans |
| 01/16/2007 | US7163813 Biological compositions and methods for treatment of colorectal cancer |
| 01/16/2007 | US7163705 Chewing gums core with coating; drug delivery |
| 01/16/2007 | US7163704 Injection made from Ixeris Sonchifolia Hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/16/2007 | US7163701 Therapy for nervous system disorders; administering nerve growth factor |
| 01/16/2007 | US7163700 Amorphous drug beads |
| 01/16/2007 | US7163699 Progestin co-micronized with a surfactant pharmaceutical composition comprising same methods for making same and uses thereof |
| 01/16/2007 | US7163698 Complex of drug and polyester |
| 01/16/2007 | US7163697 Biodegradable polymer compositions, compositions and uses related thereto |
| 01/16/2007 | US7163696 Pharmaceutical formulations |
| 01/16/2007 | US7163695 Histidine copolymer and methods for using same |
| 01/16/2007 | US7163694 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 01/16/2007 | US7163693 Comprising two or more connected sub-units, particularly for oral dosing |
| 01/16/2007 | US7163692 Foam enhancement by cationic polymers |
| 01/16/2007 | US7163690 Coating the implant device with a protein;covalently immobilizing a first substance having an amino group to the protein; adsorbing a bisphosphonate substance to the first substance, the first substance being different from the bisphosphonate substance |
| 01/16/2007 | US7163689 Administering intravenous valproate such that acute migraine headache is lessened or reduced in subject, wherein about 250 mg to 750 mg of valproate is administered to a subject over 30 minutes to 1 hour |
| 01/16/2007 | US7163688 Osmotic implant with membrane and membrane retention means |
| 01/16/2007 | US7163676 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 01/16/2007 | US7163672 Comprising an alkyl-polyglycoside surfactant and a medicament for inhalation |
| 01/16/2007 | US7163671 Stable protein formulation containing tryptophan or a tryptophan derivative or a salt thereof as a stabilizer; storage stability of hematopoietic factors such as erythropoietin |
| 01/16/2007 | CA2484724C Pharmaceutical formulations |
| 01/16/2007 | CA2401492C Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 01/16/2007 | CA2349565C Process for preparing oral calcium compositions |
| 01/16/2007 | CA2326662C Therapeutic system which can be moisture-activated |
| 01/16/2007 | CA2294196C Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| 01/16/2007 | CA2293682C Stable particle in liquid formulations |
| 01/16/2007 | CA2281473C Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| 01/16/2007 | CA2272308C Use of low molecular weight amino alcohols in ophthalmic compositions |
| 01/16/2007 | CA2253412C Microparticles and their use in wound therapy |
| 01/16/2007 | CA2252055C Fusogenic liposomes |
| 01/16/2007 | CA2247057C Non-aqueous controlled release pest and air care gel composition |
| 01/16/2007 | CA2234233C Retrievable bioartificial implants |
| 01/16/2007 | CA2190882C The production of active substance compositions in the form of a solid solution of the active substance in a polymer matrix, and active substance compositions produced by this process |
| 01/16/2007 | CA2190303C Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom |
| 01/16/2007 | CA2183952C Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation |
| 01/16/2007 | CA2154533C Opthalmic preparation for use as artificial tear |
| 01/16/2007 | CA2147283C Method of manufacturing wax matrices |
| 01/16/2007 | CA2069759C Liposomes as contrast agents for ultrasonic imaging |
| 01/11/2007 | WO2007005847A2 An electro-osmotic fluid delivery device and method |
| 01/11/2007 | WO2007005565A2 Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method |
| 01/11/2007 | WO2007004425A1 Tablet containing poorly soluble active ingredient |
| 01/11/2007 | WO2007004171A1 Device for the controlled release of a predefined quantity of a substance |
| 01/11/2007 | WO2007003972A1 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof |
| 01/11/2007 | WO2007003746A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 01/11/2007 | WO2007003481A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 01/11/2007 | WO2007003365A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/11/2007 | WO2007003278A1 Composition and dosage form comprising a solid or semi-solid matrix |
| 01/11/2007 | WO2007003113A1 A composition of raw materials for a plant polyose-containing hollow capsule and the properation method of such capsure |
| 01/11/2007 | WO2007003020A1 Oral formulations comprising ondansetron and a highly dosed sweeten |
| 01/11/2007 | WO2006121941A3 Pharmaceutical compositions comprising imatinib and a release retardant |
| 01/11/2007 | WO2006120465A3 Therapeutic sclerosing foam made preferably xenon |
| 01/11/2007 | WO2006117220A3 Method of administering a cationic liposomal preparation comprising paclitaxel |
| 01/11/2007 | WO2006109053A3 Controlled release devices and structural elements for use in their manufacture |
| 01/11/2007 | WO2006106519A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 01/11/2007 | WO2006095026A3 New soft gelatin capsules |
| 01/11/2007 | WO2006091780A3 Nanoparticulate formulations of docetaxel and analogues thereof |
| 01/11/2007 | WO2006090066A3 Spheroids prepared from an isolated active principle of vegetable origin and a solution of vegetable origin containing the active principle or a precursor thereof |
| 01/11/2007 | WO2006089651A3 Trofosfamide-containing film-coated tablets and method for the production thereof |
| 01/11/2007 | WO2006085329A3 Depolymerized polysaccharide-based hydrogel adhesive and methods of use thereof |
| 01/11/2007 | WO2006084140A3 Method for reducing the level of peroxides in bopcompatible polymer preparations |
| 01/11/2007 | WO2006083979B1 Local treatment of neurofibromas |
| 01/11/2007 | WO2006081496A3 Personal care composition containing hydrophobically modified polymers |
| 01/11/2007 | WO2006060548A3 Novel dermatological composition using bio-activating organocatalysts |
| 01/11/2007 | WO2006059152A3 Pharmaceutical formulations |